Who owns Rapport Therapeutics, Inc.?

In the current sources, Rapport Therapeutics, Inc. is connected to Bredt David, Ignelzi Troy A., Young Wendy B., Gault Cheryl, Sevigny Jeffrey and 36 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.

What is Rapport Therapeutics, Inc.'s risk level?

WhiteIntel flags Rapport Therapeutics, Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Rapport Therapeutics, Inc. appear across sources?

Rapport Therapeutics, Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

Rapport Therapeutics, Inc.

Name: Rapport Therapeutics, Inc. — ownership dossier
Creator: WhiteIntel
License: https://creativecommons.org/licenses/by/4.0/
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Rapport Therapeutics, Inc., Company, US

Medium

CompanyUS

View network JSON / MCP

Fig. 01 — Cross-source signature

/01Key factsRisk signal

Medium

Risk

Rapport Therapeutics, Inc. is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/04Ownership & control

Owners / controllers

Rapport Therapeutics, Inc.
- Bredt David· officer· via sec_form345
- Ignelzi Troy A.· officer· via sec_form345
- Young Wendy B.· director· via sec_form345
- Gault Cheryl· officer· via sec_form345
- Sevigny Jeffrey· officer· via sec_form345
- Ignelzi Troy A.· officer· via sec_form345
- Yeleswaram Krishnaswamy· officer· via sec_form345
- Bredt David· officer· via sec_form345
- Gault Cheryl· officer· via sec_form345
- Ceesay Abraham· officer· via sec_form345
- PEREZ ROBERT J· director· via SEC EDGAR
- TRV GP V, LLC· tenpercentowner· via SEC EDGAR
- TRV GP VI, LLC· tenpercentowner· via SEC EDGAR
- PAUL STEVEN M· director· via SEC EDGAR
- SANCHEZ RAMIRO· director· via SEC EDGAR
- Young Wendy B.· director· via SEC EDGAR
- Third Rock Ventures VI, L.P.· tenpercentowner· via SEC EDGAR
- SILVA PAUL M· director· via SEC EDGAR
- MARAGANORE JOHN· director· via SEC EDGAR
- Third Rock Ventures V, L.P.· tenpercentowner· via SEC EDGAR
- Third Rock Ventures GP VI, L.P.· tenpercentowner· via SEC EDGAR
- Third Rock Ventures GP V, LP· tenpercentowner· via SEC EDGAR
- HUBER REID M· director· via SEC EDGAR
- Yeleswaram Krishnaswamy· officer· via SEC EDGAR
- HEALY JAMES· director· via SEC EDGAR
- Ignelzi Troy A.· officer· via SEC EDGAR
- Ceesay Abraham· officer· via SEC EDGAR
- Sevigny Jeffrey· officer· via SEC EDGAR
- Ceesay Abraham· director· via SEC EDGAR
- Bredt David· officer· via SEC EDGAR
- Gault Cheryl· officer· via SEC EDGAR
- ARCH Venture Partners XII, L.P.· tenpercentowner· via SEC EDGAR
- Burow Kristina· tenpercentowner· via SEC EDGAR
- BURRELL TERRY-ANN· director· via SEC EDGAR
- ARCH Venture Partners XII, LLC· tenpercentowner· via SEC EDGAR
- GILLIS STEVEN· tenpercentowner· via SEC EDGAR
- CRANDELL KEITH· tenpercentowner· via SEC EDGAR
- GALER BRADLEY S.· officer· via SEC EDGAR
- NELSEN ROBERT· tenpercentowner· via SEC EDGAR
- Tong Jeffrey K· director· via SEC EDGAR
- ARCH Venture Fund XII, L.P.· tenpercentowner· via SEC EDGAR

Holdings / subsidiaries

None in current sources.

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on Rapport Therapeutics, Inc.. Notes are community-contributed leads, not verified facts.

Loading notes…